Sparse Representation-Based Patient-Specific Diagnosis and Treatment for Esophageal Squamous Cell Carcinoma

[1]  Xing Chen,et al.  MicroRNAs and complex diseases: from experimental results to computational models , 2019, Briefings Bioinform..

[2]  Xing Chen,et al.  EGBMMDA: Extreme Gradient Boosting Machine for MiRNA-Disease Association prediction , 2018, Cell Death & Disease.

[3]  Xing Chen,et al.  LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction , 2017, PLoS Comput. Biol..

[4]  Tongtong Wu,et al.  High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5 , 2017, BMC Gastroenterology.

[5]  Xing Chen,et al.  MCMDA: Matrix completion for MiRNA-disease association prediction , 2017, Oncotarget.

[6]  M. Ma,et al.  Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition , 2017, Oncotarget.

[7]  Xing Chen,et al.  Long non-coding RNAs and complex diseases: from experimental results to computational models , 2016, Briefings Bioinform..

[8]  Y. Xuan,et al.  Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma , 2016, PloS one.

[9]  Osamu Kikuchi,et al.  Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. , 2015, Gastroenterology.

[10]  T. Kanda,et al.  Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine. , 2015, International journal of oncology.

[11]  Vince D. Calhoun,et al.  Sparse representation based biomarker selection for schizophrenia with integrated analysis of fMRI and SNPs , 2014, NeuroImage.

[12]  Misha Angrist,et al.  Personalized medicine and human genetic diversity. , 2014, Cold Spring Harbor perspectives in medicine.

[13]  Jie He,et al.  Epidermal growth factor receptor is a prognosis predictor in patients with esophageal squamous cell carcinoma. , 2014, The Annals of thoracic surgery.

[14]  John N Weinstein,et al.  A curated census of autophagy-modulating proteins and small molecules , 2014, Autophagy.

[15]  M. Cazzola,et al.  Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. , 2012, Blood.

[16]  Yoichi Tanaka,et al.  Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma , 2013, Cancer science.

[17]  Jie He,et al.  Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma , 2013, World Journal of Surgical Oncology.

[18]  Xing Chen,et al.  Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..

[19]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[20]  K. Kaneko,et al.  Treatment Strategy for Superficial Pharyngeal Squamous Cell Carcinoma Synchronously Combined with Esophageal Cancer , 2012, Oncology.

[21]  Nan Hu,et al.  Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study. , 2011, Cancer epidemiology.

[22]  Shengtao Zhu,et al.  Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma. , 2011, Cancer letters.

[23]  Su-mei Li,et al.  Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma. , 2010, Chinese journal of cancer.

[24]  Quan-hong Wang,et al.  Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma , 2009, BMC Cancer.

[25]  Yaakov Tsaig,et al.  Fast Solution of $\ell _{1}$ -Norm Minimization Problems When the Solution May Be Sparse , 2008, IEEE Transactions on Information Theory.

[26]  Y. Fujii,et al.  Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[27]  D. Kwong,et al.  Identification of alpha‐actinin 4 and 67 kDa laminin receptor as stage‐specific markers in esophageal cancer via proteomic approaches , 2007, Cancer.

[28]  T. Oshikiri,et al.  The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus. , 2002, Cancer letters.

[29]  P R Taylor,et al.  Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China , 1997, Cancer.

[30]  S. Law,et al.  Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinico‐pathological study and survival analysis of 70 patients , 1997, International journal of cancer.

[31]  N. Malats,et al.  Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer. , 1997, Journal of the National Cancer Institute.

[32]  S. Law,et al.  A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia. , 1992, Surgery, gynecology & obstetrics.

[33]  J. Hiratsuka,et al.  [A case of triple cancer--gastric, esophageal and hepatocellular carcinoma]. , 1988, Gan no rinsho. Japan journal of cancer clinics.